Advocacy intelligence hub — real-time data for patient organizations
Massachusetts General Hospital — PHASE4
Amgen
Hoffmann-La Roche — PHASE3
Mohamed Moshref abd alsattar
Assiut University
Tianjin Medical University General Hospital — PHASE4
Tianjin Medical University General Hospital — PHASE1, PHASE2
Xiamen Hospital of Traditional Chinese Medicine
First Affiliated Hospital of Chongqing Medical University
Tianjin Medical University General Hospital — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Travel grants
Copay Assistance2
Travel Grants15
AMGEN Assist
Amgen
Amgen Assist 360
Amgen
Amgen By Your Side Patient Assistance Program: Uplizna
Amgen
Amgen Patient Assistance Program
Amgen
Amgen Support Plus
Amgen
Amgen SupportPlus Patient Support Program
Amgen
Enspryng Co-Pay Program
The Assistance Fund
Genentech Access to Care
Genentech
Genentech Patient Assistance
Genentech
Genentech Transplant Access Services (GTAS)
Genentech
Neuromyelitis Optica Spectrum Disorder Financial Assistance Program
The Assistance Fund
NORD RareCare Patient Assistance Program
National Organization for Rare Disorders, Inc. (NORD)
PAN Foundation Neuromyelitis Optica Spectrum Disorder Fund
PAN Foundation
PAN Foundation Neuromyelitis Optica Spectrum Disorder Patient Assistance Grant
PAN Foundation
The Assistance Fund (TAF) Neuromyelitis Optica Spectrum Disorder Fund
The Assistance Fund
He Huang, MD
Zhejiang University
📍 Hanzhou, Zhejiang
Michael Levy, MD, PhD
Johns Hopkins University
📍 Boston, Massachusetts
Dai-shi Tian, MD
Tongji Hospital
Junwei Hao, MD
Xuanwu Hospital, Beijing
Fu-Dong Shi, MD,PhD
Tianjin Medical University General Hospital
Eric Thouvenot
CHU Nimes